Osteosarcoma Institute
Donations deductibleRevenue
$4.2m
year to 31 December 2024
Expenses
$2.7m
year to 31 December 2024
Total assets
$6.3m
$82k liabilities
Net assets
$6.2m
assets less liabilities
Directors and trustees
5
4.4y av
Staff
7
employees, year to 31 December 2024
Chair observed
≥4 yrs
McHenry Tichenor Jr
Left since last filing
0
no seats appear to have opened
Osteosarcoma Institute's network
5 peoplei5 people on this map.The large node is the subject of this page. Solid lines are what the register itself records (5). Form 990 filings give names without a person identifier; SEC insider filings carry a CIK.The board
5 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations.Tenure and departures are observed across annual filings. Observed tenure is a lower bound - a member may have joined before the first year on record. The organisation reported 5 voting members of its governing body on its latest Form 990 Part VI, which matches the board listed here.| Name | Role as filed | Since | On the board |
|---|---|---|---|
| McHenry Tichenor JR Chair | Chair of Board of Trustees | 2020 | 6 yrs |
| Alli Murdoff | Board of Trustees | 2024 | 2 yrs |
| Lisa Tichenor | Board of Trustees | 2022 | 4 yrs |
| Mary Katherine Clarke | Board of Trustees | 2020 | 6 yrs |
| Michael Egge | Board of Trustees | 2024 | 2 yrs |
Under 5 years5 to 6 years6 years or more
Officers and senior leadership
2 listediNamed in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.| Name | Title as filed | On the filings |
|---|---|---|
| Dr Lee Helman | Company secretary | since 2018 |
| Lee Helman | Institute Director | since 2022 |
Pay and hours
year to 31 December 2024iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.| Name | Title as filed | Hours a week | Pay from the organisation | Related organisations | Other |
|---|---|---|---|---|---|
| Lee Helman | Institute Director | 16 | $231k | ||
| McHenry Tichenor Jr | Chair of Board of Trustees | 40 | $0 | ||
| Mary Katherine Clarke | Board of Trustees | 2 | $0 | ||
| Lisa Tichenor | Board of Trustees | 2 | $0 | ||
| Michael Egge | Board of Trustees | 2 | $0 | ||
| Alli Murdoff | Board of Trustees | 2 | $0 |
About
- Legal name
- Osteosarcoma Institute
- EIN
- 822921815
- Address
- 3963 Maple Ave Ste 390, Dallas, TX, 75219-3239
- State
- Texas
- Mission
- The mission of the osteosarcoma institute is to dramatically increase treatment options and survival rates in osteosarcoma patients through identifying and funding the most promising and breakthrough osteosarcoma clinical trials and science. (as filed on the Form 990)
- Activity (NTEE)
- H05 Medical research
- IRS classification
- 501(c)03 (tax-exempt under section 501(c)(3) where shown)
- Classified purpose
- Medical Research
- Size band
- 7 (IRS master file code)
- Formed
- 2017
- Principal officer
- McHenry Tichenor Jr (as named on the Form 990)
- IRS ruling date
- 1 May 2018
- Status
- Code 01 (unconditional exemption)
- Form 990 filings on record
- 6, latest 2024
- IRS Publication 78
- PC (contributions deductible)
Most connected
Longest observed on the filings
≥6years on the filingsMcHenry Tichenor JR
≥6years on the filingsMary Katherine Clarke
≥4years on the filingsLisa Tichenor
≥2years on the filingsAlli Murdoff
Latest return
year to 31 December 2024iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 31 December 2024. US dollars, as filed.- Total assets
- $6.3m
- Total liabilities
- $82k
- Net assets or fund balances
- $6.2m
- Contributions and grants received
- $3.9m
- Program service revenue
- $0
- Grants and similar paid out
- $1.5m
- Employees
- 7
Filed finances
1 yeariTotals as filed on the IRS Form 990 (revenue and expenses), by tax year.| Tax year | Total revenue | Total expenses | Surplus or deficit |
|---|---|---|---|
| 2024 | $4.2m | $2.7m | $1.5m |
As filed on the IRS Form 990. US dollars.
Grants paid
9 listediFrom Schedule I of the Form 990: grants and assistance to organisations in the United States, largest first (up to 25). Schedule I is filed only by organisations that gave more than $5,000 to any one recipient.| Recipient | Purpose | Amount |
|---|---|---|
| Dana Farber Cancer Institute | Clinical trial and correlative research grants | $307k |
| University of Ca San Francisco | Translational research grants | $175k |
| Regents of Emory University | Translational research grants | $125k |
| Regents of Northwestern University | Translational research grants | $125k |
| Baylor College of Medicine | Translational research grants | $125k |
| Weill Medical College of Cornell | Translational research grants | $125k |
| Regents of Stanford University | Correlative studies | $110k |
| The University of Minnesota | Translational research grant | $101k |
| The University of Florida | Correlative studies | Minus $100k |
State registration
1 entityiBusiness-entity registers published by US states. These records are matched to this organisation by name and state, not by EIN, and are labelled as likely matches. Street addresses are not shown.The Osteosarcoma Institute, Inc. likely matchiMatched by exact name and state (and ZIP where shown). State registers do not publish EINs, so this is not a confirmed match. Source: Texas Comptroller of Public Accounts, entity data (data.texas.gov 9cir-efmm). Licence not stated. Data last fetched 18 October 2026.
- State
- Texas
- Entity type
- nonprofit corporation
- Status
- Active
- Formed
- 18 August 2017
- Registered agent
- Not stated
This register does not publish officers or directors.